Assets
Create Platinum Slide Series
8 slides in article Botulinum Toxin A Versus Placebo for Refractory Detrusor Overactivity in Women: A Randomised Blinded Placebo-Controlled Trial of 240 Women (the RELAX Study)
Viewing slides 7-8 of 8
- S0302-2838(11)01441-2.results drag remove slide Results • 122 women were randomised to onaBoNT-A and 118 women placebo. Median voiding frequency was lower after onaBoNT-A compared to placebo (8.33 vs 9.67, p=0.0001). For each additional voiding ... • 122 women were randomised to onaBoNT-A and 118 women placebo. Median voiding frequency was ... Zoom
-
S0302-2838(11)01441-2.conclusion
drag
remove slide
Conclusion
• This large placebo-controlled study confirms 200 units onaBoNT-A as an effective and safe treatment for refractory DO in women.
• Urinary tract infection and voiding difficulty are ... • This large placebo-controlled study confirms 200 units onaBoNT-A as an effective and safe ... Zoom
Viewing slides 7-8 of 8
Copyright © 